The role of beta 7 integrin on cutaneous cell infiltration and melanoma
Project/Area Number |
22591217
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Dermatology
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
SATO Shinichi 東京大学, 医学部附属病院, 教授 (20215792)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 皮膚腫瘍学 / beta 7 integrin / alpha E integrin / 悪性黒色腫 / ICAM-1 / VCAM-1 / beta7インテグリン |
Research Abstract |
As leukocyte infiltration is one of the most important factors for tumor immunity in melanoma, we investigated the role of beta 7 integrin and alpha E integrin that belong to adhesion molecules implicated in leukocyte migration. The lack of alpha E integrin did not affect tumor immunity, whereas beta 7 integrin deficiency significantly augmented the tumor immunity. When beta 7 integrin is deficient, the expressions of ICAM-1 and VCAM-1 were upregulated to compensate for the loss of beta 7 integrin, which lead to the increase of Th1-type CD4-positive T cells which produced significant amount of interferon gamma.
|
Report
(4 results)
Research Products
(13 results)